A PYMNTS Company

US: SCOTUS declines antitrust case against Pfizer over Lipitor

By  |  October 10, 2018
On on Tuesday the US Supreme Court declined to review the dismissal of a lawsuit involving a group of California pharmacists who allege Pfizer conspired with Ranbaxy Laboratories to delay sales of generic versions of its cholesterol drug Lipitor.
The justices let stand a ruling by the 3rd US Circuit Court of Appeals in Philadelphia dismissing the pharmacists’ case on the grounds that the lawsuit failed to allege a violation of California antitrust law.
Full Content: Law 360, Reuters

We’d love to be your preferred source for news.

Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

Add as Preferred Source
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.